LKFN · Insider Trading
Lakeland Financial Corp
Every open-market purchase and sale reported by LKFN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-06 | Faraz Abbasi | Director | A | +24 deriv. | — |
| 2026-08-06 | Donald Robinson-Gay | Senior Vice President | Sell | −500 | −$31.50K |
| 2026-08-06 | Daniel Brian Starr | Director | A | +7 deriv. | — |
| 2026-08-06 | Darrianne P Christian | Director | A | +49 deriv. | — |
| 2026-08-06 | Blake Augsburger | Director | A | +165 deriv. | — |
| 2026-08-06 | Emily E Pichon | Director | A | +8 deriv. | — |
| 2026-08-06 | Bradley J Toothaker | Director | M | −162 deriv. | — |
| 2026-08-06 | M Scott Welch | Director | A | +507 deriv. | — |
| 2026-08-06 | Melinda Jo Truex | Director | A | +87 deriv. | — |
| 2026-08-06 | Brian J Smith | Director | A | +177 deriv. | — |
| 2026-08-06 | Faraz Abbasi | Director | A | +24 deriv. | — |
| 2026-08-06 | Emily E Pichon | Director | A | +8 deriv. | — |
| 2026-08-06 | Blake Augsburger | Director | A | +165 deriv. | — |
| 2026-08-06 | Bradley J Toothaker | Director | M | −162 deriv. | — |
| 2026-08-06 | Daniel Brian Starr | Director | A | +7 deriv. | — |
| 2026-08-06 | Darrianne P Christian | Director | A | +49 deriv. | — |
| 2026-08-06 | Melinda Jo Truex | Director | A | +87 deriv. | — |
| 2026-08-06 | Donald Robinson-Gay | Senior Vice President | Sell | −500 | −$31.50K |
| 2026-08-06 | M Scott Welch | Director | A | +507 deriv. | — |
| 2026-08-06 | Brian J Smith | Director | A | +177 deriv. | — |
| 2026-07-31 | Kyra E Clark | Senior Vice President | Sell | −250 | −$15.80K |
| 2026-07-10 | Darrianne P Christian | Director | A | +446 deriv. | — |
| 2026-07-10 | Brian J Smith | Director | A | +365 deriv. | — |
| 2026-07-10 | Blake Augsburger | Director | A | +609 deriv. | — |
| 2026-07-10 | Bradley J Toothaker | Director | A | +487 deriv. | — |
| 2026-07-10 | Faraz Abbasi | Director | A | +447 deriv. | — |
| 2026-07-10 | M Scott Welch | Director | A | +366 deriv. | — |
| 2026-07-10 | Daniel Brian Starr | Director | A | +365 deriv. | — |
| 2026-06-01 | Bradley J Toothaker | Director | Sell | −5,900 | −$357.65K |
| 2026-05-06 | Blake Augsburger | Director | A | +163 deriv. | — |
| 2026-05-06 | Daniel Brian Starr | Director | A | +4 deriv. | — |
| 2026-05-06 | Emily E Pichon | Director | A | +7 deriv. | — |
| 2026-05-06 | Melinda Jo Truex | Director | A | +88 deriv. | — |
| 2026-05-06 | Brian J Smith | Director | A | +176 deriv. | — |
| 2026-05-06 | M Scott Welch | Director | A | +510 deriv. | — |
| 2026-05-06 | Faraz Abbasi | Director | A | +21 deriv. | — |
| 2026-05-06 | Darrianne P Christian | Director | A | +46 deriv. | — |
| 2026-05-06 | Steven D Ross | Director | Sell | −1,300 | −$81.25K |
| 2026-05-06 | Bradley J Toothaker | Director | A | +160 deriv. | — |
| 2026-05-01 | Eric H Ottinger | Executive Vice President | Sell | −2,136 | −$131.34K |
| 2026-03-12 | M Scott Welch | Director | Buy | +10,000 | +$562.31K |
| 2026-03-10 | M Scott Welch | Director | Buy | +5,000 | +$277.25K |
| 2026-02-27 | M Scott Welch | Director | Buy | +10,000 | +$579.50K |
| 2026-02-24 | Bradley J Toothaker | Director | Sell | −5,685 | −$331.79K |
| 2026-02-06 | M Scott Welch | Director | A | +505 deriv. | — |
| 2026-02-06 | Blake Augsburger | Director | A | +160 deriv. | — |
| 2026-02-06 | Brian J Smith | Director | A | +173 deriv. | — |
| 2026-02-06 | Daniel Brian Starr | Director | A | +3 deriv. | — |
| 2026-02-06 | Emily E Pichon | Director | A | +8 deriv. | — |
| 2026-02-06 | Melinda Jo Truex | Director | A | +87 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| M Scott Welch | Director | 213,913 | $12.41M |
| David M Findlay | CEO | 129,099 | $7.49M |
| Melinda Jo Truex | Director | 69,889 | $4.05M |
| Brian J Smith | Director | 68,753 | $3.99M |
| Lisa M O'Neill | EVP & CFO | 41,255 | $2.39M |
| Kristin Pruitt | President | 37,394 | $2.17M |
| Eric H Ottinger | Executive Vice President | 36,419 | $2.11M |
| Robert E Bartels Jr | Director | 33,451 | $1.94M |
| Steven D Ross | Director | 27,001 | $1.57M |
| Emily E Pichon | Director | 20,148 | $1.17M |
| Blake Augsburger | Director | 18,863 | $1.09M |
| Jonathan P Steiner | Senior Vice President | 18,205 | $1.06M |
| Stephanie R Leniski | Executive Vice President | 17,088 | $991.45K |
| James Rickard Donovan | SVP, General Counsel | 15,606 | $905.46K |
| Bradley J Toothaker | Director | 14,278 | $828.41K |
| Kyra E Clark | Senior Vice President | 11,396 | $661.20K |
| Darrianne P Christian | Director | 10,750 | $623.72K |
| Jennifer M Hurford | SVP & Treasurer | 10,049 | $583.04K |
| Donald Robinson-Gay | Senior Vice President | 8,398 | $487.25K |
| Faraz Abbasi | Director | 5,850 | $339.42K |
| Brok A Lahrman | SVP, Chief Accounting Officer | 4,262 | $247.28K |
| Carrie Gutman | Senior Vice President | 2,958 | $171.62K |
| Daniel Brian Starr | Director | 1,300 | $75.43K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the LKFN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.